Skip to main content
Premium Trial:

Request an Annual Quote

Steve Nadis, Rebecca Skloot, Karen Hopkin


In his 20-odd years as a science writer, Steve Nadis, (“Roboman,” p. 32) has seen meteor craters, strange deep-sea creatures, and intestine-crawling robots. But he wasn’t on top of the latest in genome technology until robotics wizard Kevin McKernan gave him a crash course at the Whitehead Institute. Nadis was a 1997-1998 Knight Science Journalism Fellow at MIT. His articles have appeared in Nature, Scientific American, Popular Science, Atlantic Monthly, and other magazines. He lives in Cambridge, Mass., where he is often found playing handball, volleyball, and three-card gut.

Rebecca Skloot (“Blowin’ and Goin’,” p. 34) is a freelance science and medical writer who specializes in bioethics and the history of science and medicine. She contributes to a variety of publications, including San Francisco Chronicle, Chicago Tribune, Portland Tribune, and Hopkins Magazine. Before going freelance, Skloot was the assistant editor of the literary journal Creative Nonfiction and PittMed magazine. She is writing a book on the history of the HeLa cell line.

“When I was their age, I was selling my bone marrow to make the rent,” says Karen Hopkin, who interviewed the now rather wealthy founders of Neomorphic for “Metamorphic Men,” p. 29, and Spotfire CEO Chris Ahlberg ("Swede Success," p. 24) for this month''s cover story. A lab monkey-turned-science scribe, Hopkin, who holds a PhD in biochemistry, writes for such publications as Scientific American, New Scientist, Science, The Scientist — pretty much anything with “science” in the title, she says. Last year Hopkin took classes in computational genomics and pistol shooting as a Knight Fellow at MIT, and she’s currently writing a couple of chapters for Bruce Alberts’ textbook “Molecular Biology of the Cell.”

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.